These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 27810707)

  • 21. Allopregnanolone in premenstrual dysphoric disorder (PMDD): Evidence for dysregulated sensitivity to GABA-A receptor modulating neuroactive steroids across the menstrual cycle.
    Hantsoo L; Epperson CN
    Neurobiol Stress; 2020 May; 12():100213. PubMed ID: 32435664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endocrine profile of the VCD-induced perimenopausal model rat.
    Carolino ROG; Barros PT; Kalil B; Anselmo-Franci J
    PLoS One; 2019; 14(12):e0226874. PubMed ID: 31887176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lowered Plasma Steady-State Levels of Progesterone Combined With Declining Progesterone Levels During the Luteal Phase Predict Peri-Menstrual Syndrome and Its Major Subdomains.
    Roomruangwong C; Carvalho AF; Comhaire F; Maes M
    Front Psychol; 2019; 10():2446. PubMed ID: 31736837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of serum level of some trace elements and vitamin D between patients with premenstrual syndrome and normal controls: A cross-sectional study.
    Fatemi M; Allahdadian M; Bahadorani M
    Int J Reprod Biomed; 2019 Sep; 17(9):647-652. PubMed ID: 31646259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are there temporal subtypes of premenstrual dysphoric disorder?: using group-based trajectory modeling to identify individual differences in symptom change.
    Eisenlohr-Moul TA; Kaiser G; Weise C; Schmalenberger KM; Kiesner J; Ditzen B; Kleinstäuber M
    Psychol Med; 2020 Apr; 50(6):964-972. PubMed ID: 31010447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of Estrogen Therapy on the Serotonergic System in an Animal Model of Perimenopause Induced by 4-Vinylcyclohexen Diepoxide (VCD).
    Pestana-Oliveira N; Kalil B; Leite CM; Carolino ROG; Debarba LK; Elias LLK; Antunes-Rodrigues J; Anselmo-Franci JA
    eNeuro; 2018; 5(1):. PubMed ID: 29362726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathophysiology of premenstrual syndrome and premenstrual dysphoric disorder.
    Rapkin AJ; Akopians AL
    Menopause Int; 2012 Jun; 18(2):52-9. PubMed ID: 22611222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GABA receptors, progesterone and premenstrual dysphoric disorder.
    Sundström Poromaa I; Smith S; Gulinello M
    Arch Womens Ment Health; 2003 Feb; 6(1):23-41. PubMed ID: 12715262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Higher luteal progesterone is associated with low levels of premenstrual aggressive behavior and fatigue.
    Ziomkiewicz A; Pawlowski B; Ellison PT; Lipson SF; Thune I; Jasienska G
    Biol Psychol; 2012 Dec; 91(3):376-82. PubMed ID: 22906865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Food cue-elicited brain potentials change throughout menstrual cycle: Modulation by eating styles, negative affect, and premenstrual complaints.
    Strahler J; Hermann A; Schmidt NM; Stark R; Hennig J; Munk AJ
    Horm Behav; 2020 Aug; 124():104811. PubMed ID: 32592725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early- and Late-Luteal-Phase Estrogen and Progesterone Levels of Women with Premenstrual Dysphoric Disorder.
    Yen JY; Lin HC; Lin PC; Liu TL; Long CY; Ko CH
    Int J Environ Res Public Health; 2019 Nov; 16(22):. PubMed ID: 31703451
    [No Abstract]   [Full Text] [Related]  

  • 32. Cortisol awakening response is blunted and pain perception is increased during menses in cyclic women.
    Ozgocer T; Ucar C; Yildiz S
    Psychoneuroendocrinology; 2017 Mar; 77():158-164. PubMed ID: 28064085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Luteal-phase estradiol relates to symptom severity in patients with premenstrual syndrome.
    Seippel L; Bäckström T
    J Clin Endocrinol Metab; 1998 Jun; 83(6):1988-92. PubMed ID: 9626129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A specific profile of luteal phase progesterone is associated with the development of premenstrual symptoms.
    Lovick TA; Guapo VG; Anselmo-Franci JA; Loureiro CM; Faleiros MCM; Del Ben CM; Brandão ML
    Psychoneuroendocrinology; 2017 Jan; 75():83-90. PubMed ID: 27810707
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.